Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2, 3, and 4 Months Primary Schedule in Healthy Turkish Infants

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00315055
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:37.882531+00:00
Published At
2014-02-04T00:00:00+00:00
Record Updated At
2014-09-12
Results Posted At
2014-02-04
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hepatitis B", "Polio", "Diphtheria", "Pertussis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2014-09-12"
protocolSection.identificationModule.nctId
"NCT00315055"
protocolSection.identificationModule.officialTitle
"Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM\u2122 and ENGERIX B\u00ae at 2, 3, and 4 Months Primary Schedule in Healthy Turkish Infants"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2014-02-04"

Study condition terms

  • Hepatitis B (protocolSection.conditionsModule.conditions)
  • Polio (protocolSection.conditionsModule.conditions)
  • Diphtheria (protocolSection.conditionsModule.conditions)
  • Pertussis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.